Catalyst Wire Dossier Catalyst Wire Dossier

ReJoinTM

· Shanghai AbelZeta Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ReJoinTM, covering 2018-12-17 to 2018-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects [Phase 2]

See pricing